Highest-materiality recent filing
Edible Garden Q2 revenue up 12.8% to $3.6M; net loss narrows to $3.3M
Revenue $3.6M, +12.8% YoY; total sales +31.2% with cut herb +42%, potted +11.3%.
Edible Garden enters $7.2M ATM equity distribution agreement with Maxim Group
Agreement with Maxim Group LLC allows sale of up to $7,195,548 in common stock via at-the-market offering.
Edible Garden signs multi-year private label supply deal with Meijer through 2028
Agreement with Meijer Distribution, Inc. effective Jan 1, 2027 to Dec 31, 2028, replacing prior pacts.
Nasdaq Panel grants Edible Garden extension to Aug 15, 2026 for bid price compliance
Reverse stock split (1-for-45) effective July 13, 2026; closing bid price has remained at or above $1.00 since.
Edible Garden exchanges $1.13M Series B Preferred for 8.2M common shares at $0.13-$0.15/share
Exchanged 1,134 shares of Series B Preferred (stated value $1,134,000) for 8,203,075 common shares on July 8-9, 2026.
Exchanged 1,830 shares of Series B Preferred (stated value $1.83M) for 11,000,786 common shares, significantly diluting existing shareholders.
Edible Garden raises $12M via secured notes from Streeterville Capital, 18-month maturity
Issued A-1 Note of $2.17M (8% interest, $160K OID) and Secured B Note of $10M (5% interest).
Edible Garden receives Nasdaq delisting notice for bid price non-compliance; intends to appeal
Received deficiency letter on May 27, 2026 for failing minimum bid price of $1 per share for 30 consecutive business days.
Edible Garden exchanges $1.22M preferred stock for 3.25M common shares in unregistered deal
Exchanged 1,222 Series B Preferred shares ($1,000 stated value each) for 3,253,455 common shares.
Edible Garden Q1 revenue up 22.9% to $3.3M; net loss widens to $3.7M but per-share loss improves
Revenue of $3.3M (+22.9% YoY) driven by cut herb sales (+46%), vitamins (+27%), condiments (+51%), and international (+50%).
Edible Garden exchanges $3.3M preferred stock for 3.59M common shares
Exchanged 3,301 Series B Preferred shares (stated value $3,301,000) for 3,587,478 common shares.
Edible Garden Reports 2025 Results, Accelerates Expansion into RTD and Shelf-Stable CPG
Revenue for Q4 2025 was $4.1M vs $3.9M in Q4 2024; full-year revenue $12.8M vs $13.9M in 2024.
Edible Garden exchanges Series B Preferred for 670,199 common shares
On March 19, 24, and 26, 2026, exchanged 1,184 shares of Series B Preferred (stated value $1.184M) for 670,199 common shares.
Edible Garden announces 1-for-10 reverse stock split effective Feb 3, 2026
Reverse stock split at 1-for-10 ratio effective 12:01 a.m. ET on February 3, 2026.
Edible Garden preliminary holiday sales up 26.4% YoY; herbs and wheatgrass lead
Preliminary sales for Dec 14-31, 2025 rose 26.4% vs Dec 15-31, 2024; growth across core portfolio.
Edible Garden Q3 revenue up 9% to $2.8M, net loss widens to $4.0M
Revenue $2.8M (+9% YoY); non-perishable unit sales surged 49.3% YoY.
Edible Garden gets preliminary NJEDA approval to sell up to $3.35M in tax credits
NJEDA preliminarily approved Edible Garden's application under the NOL Program for FY2025, authorizing sale of up to ~$3.35M in unused NJ NOLs and R&D credits.
Edible Garden raises $4.2M via warrant exercise inducement; new warrants for 4M shares
Gross proceeds of ~$4.2M from cash exercise of Existing Warrants at reduced price of $2.06/share.
Stockholders approve reverse stock split (1:5-1:25) and new equity plans at annual meeting
Stockholders authorized reverse stock split of common stock (1:5 to 1:25) at Board discretion.
Revenue $3.1M in Q2 2025, down 28% from $4.3M in Q2 2024; net loss widened to $4.0M from $1.9M.
Edible Garden raises $3.5M via warrant inducement; issues new warrants at $3.50
Existing warrants (999,600 shares) exercised at reduced price of $3.50; original price $9.00.
Edible Garden Q1 revenue falls 13% to $2.7M; gross profit quadruples to $88K
Revenue $2.7M (-13.2% YoY) driven by exit from low-margin floral/lettuce lines.
Edible Garden acquires NaturalShrimp assets for $12M in Series B Preferred; also raises $3M cash
Acquired sustainable aquaculture assets (Fort Dodge, IA) from NaturalShrimp for $12M in 12,000 shares of Series B Preferred at $1,000 stated value.
Edible Garden sells $2.04M future receivables for net $1.435M; prepays Cedar Advance at discount
Sold $2,040,000 of future receivables to Arin Funding for $1,500,000 less $65,000 fees, netting $1,435,000.
Edible Garden gross profit surges 181% to $2.3M; gross margin triples to 16.7% in 2024
Core herb revenue grew 16.3% YoY to $1.8M, offset by exit of lettuce/floral and vitamin declines.
Edible Garden AG announces 1-for-25 reverse stock split effective March 3, 2025
Reverse stock split at 1-for-25 ratio, effective 12:01 am ET on March 3, 2025.
Edible Garden receives Nasdaq extension to March 31, 2025 for bid price compliance
Nasdaq Hearing Panel granted extension until March 31, 2025 to regain compliance with Bid Price Rule (minimum $1/share).
On August 11, 2026, Kostas Dafoulas resigned as Interim Chief Financial Officer of Edible Garden AG Incorporated (the “Company”), effective as of August 14, 2026.
On August 14, 2026, Jonathan Gutoski, age 42, was appointed Chief Financial Officer of the Company, effective August 17, 2026 and until he resigns, retires or is terminated from that position.
Effective January 25, 2024, the Board appointed Kostas Dafoulas to serve as the Company’s interim Chief Financial Officer following the retirement of Mr. James.
Effective January 25, 2024, Michael James retired from his positions as Chief Financial Officer, Treasurer, Secretary and Director of the Company.
On April 4, 2023, Deborah Pawlowski notified the Chairman of the Board of Directors of Edible Garden AG Incorporated (the “Company”) of her decision to resign, effective immediately, from her position as a member of the Company’s Board of Directors (the “Board”).
The Board appointed Pamela DonAroma to the Board, effective as of April 4, 2023.
On October 14, 2022, the board of directors (the “Board”) of Edible Garden AG Incorporated (the “Company”) appointed Deborah K. Pawlowski to the Board, effective immediately.
on May 4, 2022, the Company’s Board of Directors appointed Mathew McConnell, Tracy Nazzaro and Ryan Rogers as members of the Board of Directors
on May 4, 2022, the Company’s Board of Directors appointed Mathew McConnell, Tracy Nazzaro and Ryan Rogers as members of the Board of Directors
on May 4, 2022, the Company’s Board of Directors appointed Mathew McConnell, Tracy Nazzaro and Ryan Rogers as members of the Board of Directors
Max materiality 0.85 · Median 0.60 · Most common event other_material